Kazuma Ogawa
Kanazawa, 9201192, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 109 publications
Auger Electron Therapy Enhanced by Heat-Triggered Release of I-125-Labeled DNA-Targeted Compounds within the Tumor Microenvironment.
Journal: Molecular pharmaceutics
Published: July 27, 2026
A Bright Ratiometric Dipyrene Probe for Functional Imaging of Condensate Microenvironments in Living Cells.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 09, 2026
Macropa-Based 225Ac-Labeled RGD Peptides for Targeted Alpha Therapy.
Journal: Molecular pharmaceutics
Published: March 12, 2026
Development and Evaluation of At-211 Labeled Peptides
Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan
Published: March 01, 2026
Mechanistic insights into EGFR-Targeted: [¹²⁵I]I-rociletinib as a model small-molecule radioligand.
Journal: Tissue & cell
Published: February 18, 2026
Preparation and Evaluation of Radiolabeled Porphyrin-Functionalized Lipid Nanodroplets for Cancer Theranostics.
Journal: Molecules (Basel, Switzerland)
Published: February 13, 2026
Synthesis and Evaluation of Radiogallium-Labeled Peptide Probes for In Vivo Imaging of Legumain Activity.
Journal: Molecules (Basel, Switzerland)
Published: November 13, 2025
Comparison of Technetium-99m-Labeled Pentapeptides as Bone Imaging Agents: Influence of Different Types of Acidic Amino Acids.
Journal: Chemical & pharmaceutical bulletin
Published: October 29, 2025
Probes with Tailored Pharmacokinetics for Radiotheranostics.
Journal: Biological & pharmaceutical bulletin
Published: August 31, 2025
Development of a Theranostic Agent for Bone Metastases: Integration of Nuclear Medicine Imaging and Boron Neutron Capture Therapy (BNCT).
Journal: Molecular pharmaceutics
Published: August 20, 2025
Evaluation of an 211At-labeled RGD peptide in an orthotopic glioblastoma model by targeted alpha therapy.
Journal: Nuclear medicine and biology
Published: June 12, 2025
Engineering a Radiohybrid PSMA Ligand with an Albumin-Binding Moiety and Pharmacokinetic Modulation via an Albumin-Binding Competitor for Radiotheranostics.
Journal: Molecules (Basel, Switzerland)
Published: June 02, 2025
Last Updated: 09/26/2026